Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Follicular thyroid cancer

S K Grebe1, I D Hay

  • 1Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, USA.

Endocrinology and Metabolism Clinics of North America
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Same author

Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.

Human reproduction (Oxford, England)·2014
Same author

Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.

The Journal of clinical endocrinology and metabolism·2014
Same author

Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease.

Clinical chemistry·2007
Same author

[Papillary thyroid carcinoma: clinical manifestations, recurrences and prognosis].

Vestnik khirurgii imeni I. I. Grekova·2006
Same author

Evolving classification of renal cell neoplasia.

Expert review of anticancer therapy·2002
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Follicular thyroid cancer (FTC) is a common thyroid malignancy influenced by iodine intake and patient age. Treatment involves surgery and levothyroxine, with prognosis generally good but guarded for metastatic disease.

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Follicular thyroid cancer (FTC) is the second most common thyroid malignancy, with prevalence varying geographically, often linked to dietary iodine levels.
  • Risk factors include age over 50, female sex, and potentially genetic factors. Histological diagnosis can be challenging, distinguishing FTC from benign adenomas.
  • Vascular invasiveness and specific subtypes (oxyphilic, insular) correlate with aggressiveness and patient outcomes.

Purpose of the Study:

  • To review the epidemiology, diagnosis, treatment, and prognosis of follicular thyroid cancer.
  • To highlight diagnostic challenges and prognostic indicators for FTC.
  • To outline current management strategies and follow-up protocols for FTC patients.

Main Methods:

Related Experiment Videos

  • Review of existing literature on follicular thyroid cancer.
  • Analysis of histological features and their correlation with prognosis.
  • Summarization of treatment modalities including surgery, levothyroxine, radioiodine, and chemotherapy.

    • Main Results:

    • Geographical variations in FTC incidence are linked to iodine deficiency.
    • Vascular invasiveness, advanced age, extensive local disease, and DNA aneuploidy (in oxyphilic FTC) are adverse prognostic factors.
    • Most patients, excluding those with metastatic disease, have outcomes comparable to papillary thyroid cancer (PTC).

    Conclusions:

    • Follicular thyroid cancer management requires tailored treatment based on risk stratification.
    • Postoperative levothyroxine and radioiodine remnant ablation are key components of adjuvant therapy.
    • Intensive follow-up, particularly in the first five years, is crucial for detecting recurrence, utilizing thyroglobulin levels and radioiodine scans as needed.